chrisvoncsefalvay/vaers-outcomes huggingface dataset:
5 minutes after receiving vaccination, pt came to pharmacist because she was "itching all over" on appearance, she was flushed all over, had no visible urticaria. She was having no difficulty breathing. Was given 50 mg diphenhydramine, with minor, if any, relief. Approximately 15-20 minutes later, she noted blurred vision and dizziness. Was taken to the emergency department, given Rx's for Prednisone and Diphenhydramine.
Patient was vaccinated with his first dose of Covid Pfizer vaccine and approximately 10-11 minutes later his mother stated that he no longer felt like sitting.  He went to stand by her and 3-4 minutes later patient had a syncopal episode, fell back, and hit his head on a wall.  The patient had recovered consciousness by the time staff reached him. Our staff came to his aid and had him sit up, assessed for any signs of bleeding, which there were not, and checked vitals (results below).  Patient had no complaints of headache, no dizziness, was alert and oriented (was able to repeat name, DOB, address, and where he was), no nausea, no neck or back pain, just mentioned that he was standing then everything went dark.  He mentioned that his left arm was tingling and sore but nothing he would be alarmed about.  At the time, we suggested we monitor him an additional 15 minutes and for him to inform us if he felt any additional side effects.  At approximately 3:55pm, patient mentioned that his hands felt cold, but otherwise he had feeling and no numbness.  Patient mom was concerned and agreed to call emergency services.  Ambulance arrived and took patient to hospital at approximately 4:09pm.
Skin infection begins as a raised itchy bump that resembles an insect bite but within 1-2 days develops into a boil or pimple like sore
Left arm was hurting the evening of 4/10 then hurt really badly 4/11- 4/14, then it felt fine. Then 4/20  I noticed a big red circle on her arm. It is swollen and a little warm and tender to touch. The area of redness is a circle 5 inches in diameter  Had headaches every day since she got the vaccine, resolve with ibuprofen.  Has neck and upper back pain is still ongoing, started 4/17. First few days could not move neck side to side. She has full ROM in the neck now but still with some residual pain.
At approximately 12:08 PM, pt became dizzy and lightheaded within 3 minutes post vaccination.  Pt reported nump lips and a scratchy throat with no issues with their tongue.  Pt's vital were assessed and improved upon lying down on the cot. Pt released to husband.
Initial unsolicited report received from a physician via other company (Pfizer) (Manufacturer Report Number: 2016344812) on 01-Aug-2016. This case involves a patient (age and gender was not reported) who was vaccinated with a dose of TETANUS TOXOID and INFLUENZA VACCINE (batch number, expiration date, dose, dose in series, route and site of administration were not reported for both) on an unspecified date. Patient's medical history and concomitant medications were not reported. On an unspecified date, following vaccination, the patient developed allergy to Tetanus and Influenza Vaccine. Laboratory investigations and corrective treatment were not reported. The outcome of the event was not reported. List of documents held by sender: none.
States he was mowing his grass on 4/14/2021 and his left leg went numb.  States he was unable to walk.
Information has been received from a pharmacist concerning a 78 year old male who on 06-FEB-2007 was vaccinated with a dose of Zostavax (Merck). Concomitant therapy included lisinopril (manufacturer unknown) and lovastatin. On 13-FEB-2007, seven days after vaccination, the patient experienced a shingles rash. His rash was characterized as vesicular and extends from the left inguinal area to the left thigh and left lower back (L-1 distribution). The patient was seen in the emergency room and treated with prednisone, VALTREX and analgesic. At the time of the report, the patient had not recovered. There was no product quality complaint involved. Additional information has been requested. This is in follow-up to report(s) previously submitted on 3/14/2007. The patient was enrolled in the Varicella Zoster Identification Program to identify if VZV is present and if it is present to identify if it is associated with the wild type (WT) VZV strain of with the OKA/Merck vaccine VZV strain. On 27-FEB-2007 a specimen was obtained from a dry and crusted lesion, no fluids was available. The results from the lesion identified the presence of WT VZV. Additional information indicated from the pharmacist indicated that the patient was convinced his shingles were due to the vaccination and that he was refusing to get a flu vaccine as well as any other recommend vaccines in the future. Additional information has been requested.
Pt was given an unneeded dose of MENACTRA, pt already had received MENACTRA on 4/24/15, no adverse events noted.
I was wondering about possible side effects that I need to be looking out for; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE EVENT (I was wondering about possible side effects that I need to be looking out for) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ADVERSE EVENT (I was wondering about possible side effects that I need to be looking out for). At the time of the report, ADVERSE EVENT (I was wondering about possible side effects that I need to be looking out for) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication were reported No treatment information were reported
This case was reported by a physician and described the occurrence of blood bilirubin decreased in a 62-year-old male patient who received HAVRIX adult. Co-suspect products included Typhoid vaccine. Concomitant products included Nebivolol and Atorvastatin. On 1st September 2016, the patient received HAVRIX adult and Typhoid vaccine. On 7th September 2016, 6 days after receiving HAVRIX adult and Typhoid vaccine, the patient experienced blood bilirubin decreased. On an unknown date, the outcome of the blood bilirubin decreased was unknown. It was unknown if the reporter considered the blood bilirubin decreased to be related to HAVRIX adult and Typhoid vaccine. Additional details were provided as follows: The reporter was physician quality improvement professional. The age at vaccination was not reported. The patient's other medicines included Nebivolol and Atorvastatin 5 mg per day. The patient received HAVRIX adult and Typhoid vaccine in preparation for trip. On 2nd September 2016, the patient went for blood work and had a total bilirubin of 2.3 with otherwise normal liver enzymes. On the date of reporting, the total had fallen to 1.5 with a normal direct bilirubin. The patient was otherwise good in health and exercises daily. The reporter was interested to know if this could be a consequence of the vaccine and if so, what did it mean.
THROMBOCYTOPENIA; THROMBOSIS; BILATERAL PULMONARY EMBOLISM; This solicited report received from a patient concerned a 69 year old female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient initiated treatment with covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On an unspecified date, the patient experienced thrombocytopenia, thrombosis, and bilateral pulmonary embolism. Treatment medications (dates unspecified) included: enoxaparin sodium, and rivaroxaban. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the thrombocytopenia, thrombosis and bilateral pulmonary embolism was not reported. The reporter considered the causality between covid-19 vaccine ad26.cov2.s, and thrombocytopenia as related. The reporter did not provide a causality assessment between covid-19 vaccine ad26.cov2.s, and thrombosis, and bilateral pulmonary embolism. Company causality between covid-19 vaccine ad26.cov2.s thrombocytopenia, thrombosis, and bilateral pulmonary embolism was related.  This report was serious (Other Medically Important Condition).; Sender's Comments: V0: 20220232473-Covid-19 vaccine ad26.cov2.s-Thrombocytopenia, thrombosis, and bilateral pulmonary embolism . This event(s) is labeled per RSI and is therefore considered potentially related.
7 mins p/vax in pt rt deltoid pt collapsed, lost consciousness, had several tonic clonic movements, regained consciousness 20-30 sec later;
felt woozy/felt a little woozy; felt like they were coming down with something; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (felt woozy/felt a little woozy) and FEELING ABNORMAL (felt like they were coming down with something) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In January 2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In January 2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DIZZINESS (felt woozy/felt a little woozy) and FEELING ABNORMAL (felt like they were coming down with something). At the time of the report, DIZZINESS (felt woozy/felt a little woozy) and FEELING ABNORMAL (felt like they were coming down with something) had resolved.            The concomitant history was not reported. The treatment history was not provided.  It felt like they were coming down with something. This lasted for about 10 days.
This 70-year-old male with a history of hypertension, diabetes mellitus, chronic renal failure, DVT, TIA, sleep apnea comes to the ED for the complaint of a nonproductive cough that started 2 weeks ago.  He had a fever up to 102 °F at the home today.  He felt nauseated and vomited once today.  The patient denies any shortness of breath, chest pain or diaphoresis.  His oxygen saturation was in the 70s while ambulating. He is on peritoneal dialysis.
They are so painful, shooting pains (like electric); forehead, including me eye and cheek since getting the shingles; forehead, including me eye and cheek since getting the shingles; forehead, including me eye and cheek since getting the shingles; another shingles shot 4 years later; This case was reported by a consumer via interactive digital media and described the occurrence of pain in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles (left side of face about 12 years ago, then on right side of face 4 years ago). Previously administered products included Shingles vaccine with an associated reaction of herpes zoster (1st dose received on an unknown date, for tolerance refer case US2022AMR120528).   On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced pain, forehead headache, eye pain, facial pain and drug dose administration interval too long. Rechallenge with Shingles vaccine was positive. On an unknown date, the outcome of the pain, forehead headache, eye pain and facial pain were not recovered/not resolved and the outcome of the drug dose administration interval too long was unknown.   It was unknown if the reporter considered the pain, forehead headache, eye pain and facial pain to be related to Shingles vaccine.     Linked case(s) involving the same patient:  US2022AMR120528   Additional Information: GSK Receipt Date: 15-AUG-2022 Reporter's comment: This case was reported by a patient via interactive digital media. The patient developed shingles twice on face and it was very painful. The first episode was on left side of face about 12 years ago and second episode on right side of face 4 years ago. The patient received first shingle shot before the first episode, then another shingles shot 4 years later. The patient already received two injections of the new shingles medication and hopefully it would not get them again. They are so painful.  The patient experienced shooting pains (like electric) from forehead including eye and cheek after the shingles. Follow-up would not possible, as no contact details were available. Additional Supportive Information: The patient received 2nd dose of Shingrix, later than the recommended interval, which led to lengthening of vaccination schedule  This case had been linked with US2022AMR120528, reported by same patient.; Sender's Comments:  US-GSK-US2022AMR120528:Same patient, other dose
p/vax pt exp neck stiffness; dull ache rib cage; sore arm;
Constant ringing in ears; headaches; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 61 year-old male patient received bnt162b2 (BNT162B2), administered in arm right, administration date 05Sep2021 13:00 (Lot number: FC3184) at the age of 61 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "known allergies: Penicillin" (unspecified if ongoing), notes: known allergies: Penicillin. Concomitant medication(s) included: ENALAPRIL. Vaccination history included: Bnt162b2 (product=COVID 19, brand=Pfizer, lot number=EW0177, lot unknown=False, administration date=15Aug2021, administration time=12:00 PM, dose number=1,vaccine location=Right arm), administration date: 15Aug2021, when the patient was 60 years old, for COVID-19 immunisation. The following information was reported: TINNITUS (non-serious) with onset 06Sep2021 11:00, outcome "not recovered", described as "Constant ringing in ears"; HEADACHE (non-serious) with onset 06Sep2021 11:00, outcome "not recovered", described as "headaches". Therapeutic measures were not taken as a result of tinnitus, headache. Additional information: The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient  was not diagnosed with COVID-19, Prior to vaccination, was nor has the patient been tested for COVID-19 Since the vaccination  Pharmacy or Drug Store was the facility where the most recent COVID-19 vaccine was administered. Patient did not received any other vaccines within 4 weeks prior to the COVID vaccine. Facility where the most recent COVID-19 vaccine was administered was Pharmacy or Drug Store.  No follow-up attempts are possible. No further information is expected.
Sudden itchiness at injection site; redness;  Did not appear until after 2 weeks
Initial report received on 08 June 2009 from another manufacturer whose initial reporter was a health care professional. A 24 year old female patient received a pertussis vaccine as an infant (manufacturer and lot number not known). After receiving the vaccine, the patient experienced a seizure. No further information was provided. Recovery status was not reported. List of Documents held by Sender: none.
He noted a runny nose within a few minutes that resolved after blowing his nose. No other symptoms noted until a few days after when he started noting more exercise intolerance when on the treadmill and noting his heart rate would increase from 185 to 200. He reports no other symptoms and HR would go back to normal after cessation of exercise. He was concerned and went to the ER on 1 Sep 2021, EKG and labs unremarkable. He received his 2nd Pfizer vaccine on 2 Sep 2021 (FC3184) and noted no immediate or late symptoms other than some transient fatigue. He continued to note palpations and elevated HR with exercise and was seen by cardiology at the HCF on 29 Sep 2021.  Assessment was that patient had physiological elevated HR with exercise.
Fever, swelling from shoulder to elbow. Lymph nodes swollen.  Red rash - like bumps on abdomen.  Patient had breast cancer on right side (side of reaction).  Had mastectomy for that condition.   All:  Sulfa - hives
Patient admitted to hospital 3 days later with chest pain, ECG changes, and troponin elevation and was ultimately diagnosed with myocarditis.
cancerous cells; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 14Jan2021 at single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient received her first dose of PFIZER-BIONTECH COVID-19 VACCINE on 14Jan2021. She had a surgical procedure Wednesday 20Jan2021, and was prescribed a cephalosporin antibiotic for 7 days post-procedure precautionary remove cancerous cells somebody suggested, it was a doctor. She was asking if there are any drug interactions between the antibiotic and the vaccine. Also, a doctor suggested that she take a dose of ibuprofen prior to her second vaccine dose on 05Feb2021. It was also reported the patient had a little surgical procedure with the Dermatologist this week (in Jan2021) and she just wanted to know if the antibiotic, Cefadroxil, has any contraindications that would compromise her vaccine. She had to take it for 7 days and it was to prevent bacterial infections. It was a procedure on her leg and she was also given an antibiotic cream also to help. The patient felt it was more important for her with having this vaccine and that was why she was calling. The event outcome was unknown.  Information on the Batch/Lot number has been requested.
Severe arm pain, 9/10, pain in left arm. Limited range of motion in left arm at least 9 days, post vaccination.
This spontaneous report was received from a nurse and refers to a patient of an unknown age and gender. There was no information regarding the patient's pertinent medical history, drug reactions, allergies or concomitant therapies provided. On 03-JAN-2017, the patient was vaccinated with an improperly stored doses of M-M-R II, lot # M015931, expiration date 30-MAR-2018 (site, dose and route of administration were not reported). The reason of the call was temperature alarm received via Digital Data Logger. It was reported that the vaccine was exposed to temperature of -14.4 Celsius degrees for 54 minutes before administration to the patient. No previous temperature excursion was reported. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information is not expected, all information has already been obtained. Sender's Comments: US-009507513-1611USA011831: US-009507513-1611USA004113:
About 7 hours after vaccination, muscle aches, chills, fever, nausea. Lasted for around 12 hours. Took Tylenol as treatment, helped lessen the symptoms.
Patient with a complex medical history presented to ED with symptoms of malaise, nausea/vomiting, weakness, and pre-syncope associated with poor oral intake persisting through 36 hours after COVID-19 vaccine booster dose #2. Symptoms improved with IV fluids. Diagnostic work-up revealed non-ischemic myocardial injury associated with hypovolemia and moderate aortic stenosis. Patient was discharged with definitive outpatient treatment plan in place.
Headache, Myalgia, Diarrhea, cough, fatigue Narrative:
Infection; White blood count and other things like neutrophils and monocytes were all high; White blood count and other things like neutrophils and monocytes were all high; leukocytes to go high; she felt just kind of a little bit under the weather show, that's what we say, not great; Chills; This is a spontaneous report from a contactable consumer (patient). A 79-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/lot number: unknown), via unspecified route of administration, administered in the left upper arm, on 02Mar2021 (age at vaccination 79-year-old), as dose 1, single for COVID-19 Immunization. Medical history included hypertension. Concomitant medications were not reported. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on an unknown date at the age of 79 year, as dose 1, single for COVID-19 Immunization. Patient had the second shot on 02Mar. So, the next day (03 Mar2021) patient had chills and the next day (04Mar2021) she felt just kind of a little bit under the weather show, that's what we say, not great. And on 05Mar, it was her blood work and she thought that the vaccine caused her white blood cells and leukocytes to go high, to try to fight off this infection. She just wondered if other people had that same results. Her doctor on 05Mar2021, got her report and she just thought it was very strange that her white blood count and the other things like the neutrophils and the monocytes, they were all high. And she thought it was probably the vaccine because that thing kind of gave you like a little, mild infection. Also reported that patient sat in a room for 15 minutes after the shot. she felt okay. Patient have a little high blood pressure. She was going go to see her heart doctor. she just wanted to know has any other person reported that white blood cells were high because of the vaccine. The outcome of the events was unknown.  No follow up attempts are possible. Information about lot/batch number cannot been obtained.
The shot in my left arm initially hurt more than usual. Around 1pm my arm started to ache and also my shoulder. A couple hours later it spread down my arm. The next day it spread to my left leg and then the right side of my body as well. The left arm and shoulder hurt the worst and the pain continues and is constant in arm and shoulder and is varied through rest of body. Dr. prescribed gabapentin which helps but doesn't entirely alleviate pain. Believes it to be permanent nerve damage.
pt rt arm swollen & red in color which started on 14JUN96;17JUN96 pt rt ram remains swollen & red in color;has applied cold moist & compress to area;poss allerg rxn;pt rt arm also sore;
2 days after vaccination, patient developed intermittent dry cough and palpitations that are worsening. Has not been diagnosed with COVID-19 prior.
Speech and Language delay noted at one year of age 4/12/2000- started the first words program.  Diagnosed with 25% language delay at 2 years of age 6/27/2001 thru speech pathologist; began language therapy.  Diagnosed with autism at 3 yr 3mos(7-9-2002). Per follow up report-Chronis Dysbiosis, Gluten and Caseine sensitivity, heavy metal toxicity, metabolism problems. 12/31/09 Continues to have slow processing speed, intsteinal dysbiosis easily distracted.
I went to the doctor on March 30, 2021 and was prescribed Flonase. Mid to high back pain Arm soreness Blood in my sputum & mucus problems Cough Headaches Sinus pressure Moments of insomnia  Fatigue There has been in a change in my menstrual cycle: my period has been very irregular and my period lasts longer.   I went to the doctor in February and took an x-ray. I also went to the doctor on March 30, 2021 and was prescribed Flonase.
03/17/2022 I spent 6 out of 7 days in bed and then I was up and then back in bed for 5 days. The issues with this shot were so different. I may have been in pain but not nearly as bad as the first time. I was just too tired to do anything outside of feeding my pts and then eating myself and then back to bed. I remember being in the bed for 5 days and then everything was fine.
After the vaccine I was fatigue, body aches. sore arm for both of the vaccines. I tested positive for COVID-19 on January 13, 2022.
Redden area 2 1/4" wide 2 3/4" long sore and tender to touch, area firm to touch.